Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts

Journal of Cellular Biochemistry

Volumn 105, Issue 4, 2008, Pages 1128-1138

  Roelofsen, T ^a,b   Akkers, R ^a,b   Beumer, W ^b,c   Apotheker, M ^b   Steeghs, I ^b   Van De Ven, J ^b   Gelderblom, C ^b   Garritsen, A ^b   Dechering, K ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Bone morphogenetic protein; Migration; Osteoblasts; Platelet derived growth factor; Sphingosine 1 phosphate

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PLATELET DERIVED GROWTH FACTOR A; SPHINGOSINE 1 PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE REMODELING; C57BL 6 MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CHEMOTAXIS; DEVELOPMENTAL STAGE; FRACTURE HEALING; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RNA INTERFERENCE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOTAXIS; HUMANS; LYSOPHOSPHOLIPIDS; MICE; OSTEOBLASTS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

EID: 55549103388     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21915     Document Type: Article

References (44)

1. Alvarez SE, Milstien S, Spiegel S. 2007. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 18:300-307.
2. Anliker B, Chun J. 2004. Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol 15:457-465.
3. Bonyadi M, Waldman SD, Liu D, Aubin JE, Grynpas MD, Stanford WL. 2003. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 100:5840-5845.
4. Dimitriou R, Tsiridis E, Giannoudis PV. 2005. Current concepts of molecular aspects of bone healing. Injury 36:1392-1404.
5. Dobnig H, Turner RT. 1995. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638.
6. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM. 2004. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA 101:11761-11766.
7. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
8. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S. 2005. Circulating osteoblast-lineage cells in humans. N Engl J Med 352:1959-1966.
9. Fiedler J, Roderer G, Gunther KP, Brenner RE. 2002. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87:305-312.
10. Fiedler J, Etzel N, Brenner RE. 2004. To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990-998.
11. Fink EE, Eghbali-Fatourechi GZ, Khosla S. 2007. Remodeling and vascular spaces in bone. J Bone Miner Res 22:1-6.
12. Fujii H, Kitazawa R, Maeda S, Mizuno K, Kitazawa S. 1999. Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse. Histochem Cell Biol 112:131-138.
13. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T. 2004. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166:85-95.
14. Fukuyama R, Fujita T, Azuma Y, Hirano A, Nakamuta H, Koida M, Komori T. 2004. Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling. Biochem Biophys Res Commun 315:636-642.
15. Godwin SL, Soltoff SP. 1997. Extracellular calcium and platelet-derived growth factor promote receptor-mediated chemotaxis in osteoblasts through different signaling pathways. J Biol Chem 272:11307-11312.
16. Goparaju SK, Jolly PS, Watterson KR, Bektas M, Alvarez S, Sarkar S, Mel L, Ishii I, Chun J, Milstien S, Spiegel S. 2005. The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol Cell Biol 25:4237-4249.
17. Hankenson KD, Bain SD, Kyriakides TR, Smith EA, Goldstein SA, Bornstein P. 2000. Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15:851-862.
18. Hobson JP, Rosenfeldt HM, Barak LS, Olivera A, Poulton S, Caron MG, Milstien S, Spiegel S. 2001. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291:1800-1803.
19. Khosla S, Eghbali-Fatourechi GZ. 2006. Circulating cells with osteogenic potential. Ann NY Acad Sci 1068:489-497.
20. Kono M, Belyantseva IA, Skoura A, Frolenkov GI, Starost MF, Dreier JL, Lidington D, Bolz SS, Friedman TB, Hla T, Proia RL. 2007. Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 282:10690-10696.
21. Lee MJ, Thangada S, Paik JH, Sapkota GP, Ancellin N, Chae SS, Wu M, Morales-Ruiz M, Sessa WC, Alessi DR, Hla T. 2001. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell 8:693-704.
22. Lepley D, Paik JH, Hla T, Ferrer F. 2005. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res 65:3788-3795.
23. Lyons JM, Karin NJ. 2001. A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells. J Bone Miner Res 16:2035-2042.
24. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A. 2000. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311-320.
25. Masiello LM, Fotos JS, Galileo DS, Karin NJ. 2006. Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells. Bone 39:72-82.
26. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-360.
27. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ. 1994. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15:203-208.
28. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H, Ozaki Y. 2003. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 58:170-177.
29. Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H, Takuwa Y. 2000. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 20:9247-9261.
30. Ozeki N, Jethanandani P, Nakamura H, Ziober BL, Kramer RH. 2007. Modulation of satellite cell adhesion and motility following BMP2-induced differentiation to osteoblast lineage. Biochem Biophys Res Comm 353:54-59.
31. Parfitt AM, 2001. The bone remodeling compartment: A circulatory function for bone lining cells. J Bone Miner Res 16:1583-1585.
32. Rosen H, Goetzl EJ. 2005. Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network. Nature Rev Immunol 7:560-570.
33. Sanchez T, Thangada S, Wu MT, Kontos CD, Wu D, Wu H, Hla T. 2005. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci USA 102:4312-4317.
34. Shagin DA, Barsova EV, Yanushevich YG, Fradkov AF, Lukyanov KA, Labas YA, Semenova TN, Ugalde JA, Meyers A, Nunez JM, Widder EA, Lukyanov SA, Matz MV. 2004. GFP-like proteins as ubiquitous metazoan superfamily: Evolution of functional features and structural complexity. Mol Biol Evol 21:841-850.
35. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y. 2003. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 23:1534-1545.
36. Swift S, Lorens J, Achacoso P, Nolan GP. 1999. Radid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. In: Coligan JE, Bierer B, Margulies DH, Shevach EM, Strober W, Coico R, editors. Current protocols in immunology. Wiley Interscience. pp. 14-29.
37. ten Dijke, P. 2006. Bone morphogenetic protein signal transduction in bone. Curr Med Res Opin 22 (Suppl 1): s7-s11.
38. Thomas D, Kansara M. 2006. Epigenetic modifications in osteogenic differentiation and transformation. J Cell Biochem 98:757-769.
39. Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Lefevre C, Mummery CL, Olijve W, van Zoelen EJ, Steegenga WT. 2002. Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res 17:2106-2118.
40. Vaes BL, Ducy P, Sijbers AM, Hendriks JM, van Someren EP, de Jong NG, van den Heuvel ER, Olijve W, van Zoelen EJ, Dechering KJ. 2006. Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation. Bone 39:724-738.
41. Waters CM, Long J, Gorshkova I, Fujiwara Y, Connell M, Belmonte KE, Tigyi G, Natarajan V, Pyne S, Pyne NJ. 2006. Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. FASEB J 20:509-511.
42. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. 2002. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101-110.
43. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, Kume S. 1997. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 121:969-973.
44. Yokoo E, Yatomi Y, Takafuta T, Osada M, Okamoto Y, Ozaki Y. 2004. Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1 P2: Cross-talk between platelets and mast cells. J Biochem (Tokyo) 135:673-681.